Stephen Willey
Stock Analyst at Stifel Nicolaus
(4.56)
# 1,003
Out of 4,978 analysts
612
Total ratings
45.9%
Success rate
10.7%
Average return
Main Sectors:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EXEL Exelixis | Reiterated: Hold | n/a | $56.90 | - | 56 | Sep 11, 2026 | |
| LYEL Lyell Immunopharma | Reiterated: Buy | $36 | $10.91 | +229.97% | 3 | Sep 11, 2026 | |
| PYXS Pyxis Oncology | Reiterated: Buy | $8 → $7 | $3.33 | +110.21% | 7 | Aug 17, 2026 | |
| CADL Candel Therapeutics | Reiterated: Buy | $22 | $11.12 | +97.84% | 2 | Aug 14, 2026 | |
| CELC Celcuity | Reiterated: Buy | $175 → $150 | $82.70 | +81.38% | 11 | Aug 14, 2026 | |
| CMPX Compass Therapeutics | Reiterated: Buy | $6 | $1.85 | +224.32% | 14 | Aug 14, 2026 | |
| MGNX MacroGenics | Reiterated: Hold | $4 | $4.04 | -0.99% | 36 | Aug 14, 2026 | |
| NKTX Nkarta | Reiterated: Buy | $11 → $10 | $2.88 | +247.22% | 26 | Aug 14, 2026 | |
| SNDX Syndax Pharmaceuticals | Reiterated: Buy | $40 | $18.09 | +121.12% | 10 | Aug 14, 2026 | |
| BCAX Bicara Therapeutics | Reiterated: Buy | $46 → $45 | $22.67 | +98.50% | 15 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $16.44 | +112.90% | 6 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $26.05 | +76.58% | 34 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $4.35 | +106.90% | 11 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $9 | $11.41 | -21.12% | 19 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $28 | $18.80 | +48.94% | 18 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $111 | $67.30 | +64.93% | 11 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $123 → $145 | $121.74 | +19.11% | 40 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $119.92 | +66.78% | 30 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $34 → $40 | $24.83 | +61.10% | 30 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $22.32 | +79.21% | 24 | Apr 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $5.47 | +210.79% | 6 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $7.5 | $3.62 | +107.18% | 17 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $6.69 | n/a | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $20 | $4.03 | n/a | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.31 | n/a | 16 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $31.64 | n/a | 15 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.42 | n/a | 10 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $6 | $1.09 | n/a | 17 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $5 | $0.83 | n/a | 4 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $4.25 | n/a | 6 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $1 | $1.16 | n/a | 15 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $27 | $1.13 | n/a | 4 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $2.01 | n/a | 11 | Mar 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $21 | $56.28 | n/a | 5 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $160 | $3.75 | n/a | 1 | Mar 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $95 → $125 | $238.27 | n/a | 6 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $109 → $114 | $64.45 | n/a | 14 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 → $48 | $47.25 | n/a | 13 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $16 | $20.84 | n/a | 13 | Apr 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $2.5 | $0.0001 | n/a | 3 | Sep 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $26 | $13.72 | n/a | 2 | Apr 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $1.76 | n/a | 1 | Feb 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $7.89 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $240.83 | n/a | 1 | May 31, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.32 | n/a | 5 | Dec 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $101 | - | n/a | 5 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $26 | $5.06 | n/a | 3 | Nov 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $7 | $44.36 | n/a | 2 | Apr 8, 2013 |
Exelixis
Sep 11, 2026
Reiterated: Hold
Price Target: n/a
Current: $56.90
Upside: -
Lyell Immunopharma
Sep 11, 2026
Reiterated: Buy
Price Target: $36
Current: $10.91
Upside: +229.97%
Pyxis Oncology
Aug 17, 2026
Reiterated: Buy
Price Target: $8 → $7
Current: $3.33
Upside: +110.21%
Candel Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $22
Current: $11.12
Upside: +97.84%
Celcuity
Aug 14, 2026
Reiterated: Buy
Price Target: $175 → $150
Current: $82.70
Upside: +81.38%
Compass Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $6
Current: $1.85
Upside: +224.32%
MacroGenics
Aug 14, 2026
Reiterated: Hold
Price Target: $4
Current: $4.04
Upside: -0.99%
Nkarta
Aug 14, 2026
Reiterated: Buy
Price Target: $11 → $10
Current: $2.88
Upside: +247.22%
Syndax Pharmaceuticals
Aug 14, 2026
Reiterated: Buy
Price Target: $40
Current: $18.09
Upside: +121.12%
Bicara Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $46 → $45
Current: $22.67
Upside: +98.50%
Aug 11, 2026
Reiterated: Buy
Price Target: $35
Current: $16.44
Upside: +112.90%
Aug 11, 2026
Reiterated: Buy
Price Target: $46
Current: $26.05
Upside: +76.58%
Aug 7, 2026
Reiterated: Buy
Price Target: $9
Current: $4.35
Upside: +106.90%
Aug 6, 2026
Reiterated: Buy
Price Target: $8 → $9
Current: $11.41
Upside: -21.12%
Jul 31, 2026
Reiterated: Buy
Price Target: $30 → $28
Current: $18.80
Upside: +48.94%
Jul 31, 2026
Reiterated: Buy
Price Target: $111
Current: $67.30
Upside: +64.93%
Jul 28, 2026
Reiterated: Buy
Price Target: $123 → $145
Current: $121.74
Upside: +19.11%
Jul 17, 2026
Reiterated: Buy
Price Target: $200
Current: $119.92
Upside: +66.78%
Jul 10, 2026
Rated: Buy
Price Target: $34 → $40
Current: $24.83
Upside: +61.10%
Apr 8, 2026
Reiterated: Buy
Price Target: $40
Current: $22.32
Upside: +79.21%
Mar 18, 2026
Reiterated: Buy
Price Target: $17
Current: $5.47
Upside: +210.79%
Nov 5, 2025
Reiterated: Buy
Price Target: $9 → $7.5
Current: $3.62
Upside: +107.18%
Jun 24, 2025
Initiated Coverage: Buy
Price Target: $28
Current: $6.69
Upside: n/a
May 13, 2025
Reiterated: Hold
Price Target: $25 → $20
Current: $4.03
Upside: n/a
Mar 12, 2025
Reiterated: Buy
Price Target: $4
Current: $1.31
Upside: n/a
Nov 15, 2024
Reiterated: Buy
Price Target: $4
Current: $31.64
Upside: n/a
Nov 6, 2024
Reiterated: Buy
Price Target: $4
Current: $2.42
Upside: n/a
May 14, 2024
Reiterated: Hold
Price Target: $7 → $6
Current: $1.09
Upside: n/a
May 13, 2022
Reiterated: Hold
Price Target: $9 → $5
Current: $0.83
Upside: n/a
May 13, 2022
Reiterated: Hold
Price Target: $6 → $5
Current: $4.25
Upside: n/a
May 11, 2022
Reiterated: Hold
Price Target: $3 → $1
Current: $1.16
Upside: n/a
Mar 12, 2021
Reiterated: Buy
Price Target: $25 → $27
Current: $1.13
Upside: n/a
Mar 11, 2021
Reiterated: Hold
Price Target: $6
Current: $2.01
Upside: n/a
Mar 29, 2019
Reiterated: Buy
Price Target: $18 → $21
Current: $56.28
Upside: n/a
Mar 14, 2019
Reiterated: Hold
Price Target: $160
Current: $3.75
Upside: n/a
Aug 6, 2018
Upgraded: Buy
Price Target: $95 → $125
Current: $238.27
Upside: n/a
Aug 6, 2018
Reiterated: Buy
Price Target: $109 → $114
Current: $64.45
Upside: n/a
Aug 6, 2018
Reiterated: Hold
Price Target: $55 → $48
Current: $47.25
Upside: n/a
Apr 27, 2018
Reiterated: Hold
Price Target: $17 → $16
Current: $20.84
Upside: n/a
Sep 26, 2017
Downgraded: Hold
Price Target: $13 → $2.5
Current: $0.0001
Upside: n/a
Apr 4, 2017
Reiterated: Buy
Price Target: $20 → $26
Current: $13.72
Upside: n/a
Feb 2, 2017
Reiterated: Buy
Price Target: $24
Current: $1.76
Upside: n/a
Dec 2, 2016
Reiterated: Buy
Price Target: $23
Current: $7.89
Upside: n/a
May 31, 2016
Reiterated: Buy
Price Target: $200
Current: $240.83
Upside: n/a
Dec 2, 2015
Downgraded: Hold
Price Target: n/a
Current: $7.32
Upside: n/a
Mar 31, 2015
Downgraded: Hold
Price Target: $101
Current: -
Upside: n/a
Nov 7, 2014
Reiterated: Buy
Price Target: $31 → $26
Current: $5.06
Upside: n/a
Apr 8, 2013
Reiterated: Buy
Price Target: $11 → $7
Current: $44.36
Upside: n/a